Benefit Finding Scale for Children: preliminary findings from a childhood cancer population

Sean Phipps1, Alanna M Long, Johanna Ogden

  • 1Division of Behavioral Medicine, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA. sean.phipps@stjude.org

Insights

A new Benefit Finding Scale for Children (BFSC) was developed and validated. This brief measure shows promise for assessing benefit finding in pediatric populations, including children with cancer.

Area of Science:

  • Psychology
  • Pediatric Oncology
  • Child Development

Background:

  • Benefit finding is a key aspect of post-traumatic growth.
  • Assessing benefit finding in children requires a brief, valid instrument.
  • Previous measures may not be suitable for pediatric populations.

Purpose of the Study:

  • To develop and validate the Benefit Finding Scale for Children (BFSC).
  • To examine the psychometric properties of the BFSC in children with cancer.

Main Methods:

  • A cross-sectional study involved 199 children (ages 7-18) with cancer.
  • Participants completed the BFSC, alongside measures of adaptive style, optimism, PTSD symptoms, and quality of life.
  • Statistical analyses examined reliability, validity, and relationships with other variables.

Main Results:

  • The BFSC demonstrated unidimensionality and excellent internal reliability.
  • Benefit finding correlated positively with optimism and self-esteem, and negatively with anxiety.
  • No significant relationships were found with PTSD symptoms or overall quality of life.

Conclusions:

  • The Benefit Finding Scale for Children (BFSC) is a promising, brief measure.
  • The BFSC can be utilized in research and clinical settings for children experiencing adversity.
  • The scale's adaptability suggests potential use in other pediatric trauma populations.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...